Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Revenue (2020 - 2025)

Historic Revenue for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $993.7 million.

  • Alignment Healthcare's Revenue rose 4350.77% to $993.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 4739.01%. This contributed to the annual value of $2.7 billion for FY2024, which is 4825.16% up from last year.
  • Per Alignment Healthcare's latest filing, its Revenue stood at $993.7 million for Q3 2025, which was up 4350.77% from $1.0 billion recorded in Q2 2025.
  • Over the past 5 years, Alignment Healthcare's Revenue peaked at $1.0 billion during Q2 2025, and registered a low of $267.1 million during Q1 2021.
  • In the last 5 years, Alignment Healthcare's Revenue had a median value of $456.7 million in 2023 and averaged $529.7 million.
  • In the last 5 years, Alignment Healthcare's Revenue surged by 1839.66% in 2021 and then surged by 5161.36% in 2024.
  • Quarter analysis of 5 years shows Alignment Healthcare's Revenue stood at $298.3 million in 2021, then increased by 21.3% to $361.8 million in 2022, then rose by 28.63% to $465.4 million in 2023, then surged by 50.68% to $701.2 million in 2024, then skyrocketed by 41.71% to $993.7 million in 2025.
  • Its Revenue was $993.7 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $926.9 million in Q1 2025.